|
 Liv.52 HB, a US patent-pending phytopharmaceutical formulation, is recommended for the treatment of hepatitis B. Liv.52 HB protects the liver against various hepatotoxins, exerts antiviral activity and enhances the antioxidant defense system. The drug is safe even after long-term administration. It has antiviral, hepatoprotective, anti-inflammatory, immunomodulatory, and antioxidant properties, too.
Liv.52 HB suppresses the replication of viral DNA involved in hepatitis B, and eliminates the hepatitis B virus (HBV). It suppresses the HBV by binding with the hepatitis B surface antigen (HBsAg). It also prevents the loss of functional integrity of hepatic cell membranes, and ensures early restoration of hepatic functions in hepatitis B, due to its antiperoxidative activity. Liv.52 HB also protects the hepatic parenchyma and promotes hepatocellular regeneration.
|
|
